Session Type
Meeting
Search Results for Addiction
Abstract Number: 224
SHM Converge 2021
Background: Biases related to people with substance use disorder (SUD) actually increase during time spent in formal medical education, and continue into practice. Leading health professional education groups across medicine, nursing, pharmacy, and social work, including the Association of American Medical Colleges (AAMC), have recognized addressing substance use disorders including stigma and bias as a […]
Abstract Number: 301
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Persons with opioid use disorder (OUD) represent an estimated 4-11% of hospitalized patients and are increasingly admitted for opioid-related complications. In response to the opioid epidemic, national organizations have recommended hospitals develop protocols to engage patients with OUD in opioid agonist treatment (OAT) during hospitalization. Buprenorphine is an effective OAT for OUD that is […]
Abstract Number: 351
SHM Converge 2024
Background: There were 527,000 hospitalizations due to opioid use in 2012, which equates to more than $15 billion in medical care costs (Ronan & Herzig, 2016). Providers report significant barriers in treating patients with substance use disorders (SUDs), including feelings of unpreparedness to treat addiction (Calcaterra et al., 2021). Advance practice provider (APP) education lacks […]
Abstract Number: 707
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Case Presentation: A 26 year old man with past medical history of obstructive sleep apnea and oxycodone abuse presented to the emergency department after cardiac arrest. According to family members, the patient was seen ingesting an unknown quantity of ibogaine at home with the main purpose of treating his opioid addiction. Shortly after ingestion, the […]
Abstract Number: 812
SHM Converge 2023
Case Presentation: A 34-year-old male with a history of opioid use disorder (OUD) was admitted after being found down secondary to heroin overdose. He was given 4 mg naloxone in the field with improvement in Glasgow Coma Score from 3 to 12. After naloxone administration, he was tachycardic, tachypneic, hypertensive, and agitated. He reported taking […]
Abstract Number: 848
SHM Converge 2023
Case Presentation: A 43-year-old woman with general anxiety disorder and benzodiazepine abuse was brought to the emergency department by her husband with nausea, diarrhea, agitation, and altered mental status. She also endorsed restlessness and muscle tension. Examination revealed an agitated, disoriented woman with three days of amnesia. Vitals signs were within normal limits. Drug and […]
Abstract Number: A17
SHM Converge 2022
Background: Although most cigarette smokers want to quit, current cessation therapies have limited effectiveness. Preventing relapse is limited by insufficient understanding of the neural pathways that are triggered during relapse. With recent advances in functional connectivity analysis, functional magnetic resonance imaging (fMRI) studies offer the ability to better neural functional connectivity during relapse. This study […]
Oral Presentations
Abstract Number: Oral
SHM Converge 2021
Background: Despite evidence that the use of medications for patients with opioid use disorder (OUD) leads to reduced mortality and improved engagement in outpatient addiction treatment, these life-saving medications are underutilized in the hospital setting. This study reports the outcomes of a hospitalist-led interprofessional and multidisciplinary inpatient program, known as the B-Team (buprenorphine team), to […]